The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Armodafinil Market Research Report 2025
Synopsis
Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.
The global Armodafinil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Armodafinil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Armodafinil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Armodafinil in Obstructive Sleep Apnea (OSA) and Narcolepsy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Armodafinil include Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma and Aurobindo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Armodafinil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Armodafinil.
Report Scope
The Armodafinil market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Armodafinil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Armodafinil companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo
Segment by Type
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets
Segment by Application
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Armodafinil companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.
The global Armodafinil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Armodafinil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Armodafinil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Armodafinil in Obstructive Sleep Apnea (OSA) and Narcolepsy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Armodafinil include Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma and Aurobindo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Armodafinil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Armodafinil.
Report Scope
The Armodafinil market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Armodafinil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Armodafinil companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo
Segment by Type
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets
Segment by Application
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Armodafinil companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Armodafinil Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 50 mg Tablets
1.2.3 150 mg Tablets
1.2.4 200 mg Tablets
1.2.5 250 mg Tablets
1.3 Market by Application
1.3.1 Global Armodafinil Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
1.3.3 Shift Work Disorder (SWD)
1.3.4 Patients with Severe Hepatic Impairment
1.3.5 Geriatric Patients
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Armodafinil Market Perspective (2019-2030)
2.2 Armodafinil Growth Trends by Region
2.2.1 Global Armodafinil Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Armodafinil Historic Market Size by Region (2019-2024)
2.2.3 Armodafinil Forecasted Market Size by Region (2025-2030)
2.3 Armodafinil Market Dynamics
2.3.1 Armodafinil Industry Trends
2.3.2 Armodafinil Market Drivers
2.3.3 Armodafinil Market Challenges
2.3.4 Armodafinil Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Armodafinil Players by Revenue
3.1.1 Global Top Armodafinil Players by Revenue (2019-2024)
3.1.2 Global Armodafinil Revenue Market Share by Players (2019-2024)
3.2 Global Armodafinil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Armodafinil Revenue
3.4 Global Armodafinil Market Concentration Ratio
3.4.1 Global Armodafinil Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Armodafinil Revenue in 2023
3.5 Armodafinil Key Players Head office and Area Served
3.6 Key Players Armodafinil Product Solution and Service
3.7 Date of Enter into Armodafinil Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Armodafinil Breakdown Data by Type
4.1 Global Armodafinil Historic Market Size by Type (2019-2024)
4.2 Global Armodafinil Forecasted Market Size by Type (2025-2030)
5 Armodafinil Breakdown Data by Application
5.1 Global Armodafinil Historic Market Size by Application (2019-2024)
5.2 Global Armodafinil Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Armodafinil Market Size (2019-2030)
6.2 North America Armodafinil Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Armodafinil Market Size by Country (2019-2024)
6.4 North America Armodafinil Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Armodafinil Market Size (2019-2030)
7.2 Europe Armodafinil Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Armodafinil Market Size by Country (2019-2024)
7.4 Europe Armodafinil Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Armodafinil Market Size (2019-2030)
8.2 Asia-Pacific Armodafinil Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Armodafinil Market Size by Region (2019-2024)
8.4 Asia-Pacific Armodafinil Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Armodafinil Market Size (2019-2030)
9.2 Latin America Armodafinil Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Armodafinil Market Size by Country (2019-2024)
9.4 Latin America Armodafinil Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Armodafinil Market Size (2019-2030)
10.2 Middle East & Africa Armodafinil Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Armodafinil Market Size by Country (2019-2024)
10.4 Middle East & Africa Armodafinil Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Armodafinil Introduction
11.1.4 Teva Revenue in Armodafinil Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Armodafinil Introduction
11.2.4 Mylan Revenue in Armodafinil Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 Apotex
11.3.1 Apotex Company Detail
11.3.2 Apotex Business Overview
11.3.3 Apotex Armodafinil Introduction
11.3.4 Apotex Revenue in Armodafinil Business (2019-2024)
11.3.5 Apotex Recent Development
11.4 Lupin
11.4.1 Lupin Company Detail
11.4.2 Lupin Business Overview
11.4.3 Lupin Armodafinil Introduction
11.4.4 Lupin Revenue in Armodafinil Business (2019-2024)
11.4.5 Lupin Recent Development
11.5 Sandoz
11.5.1 Sandoz Company Detail
11.5.2 Sandoz Business Overview
11.5.3 Sandoz Armodafinil Introduction
11.5.4 Sandoz Revenue in Armodafinil Business (2019-2024)
11.5.5 Sandoz Recent Development
11.6 Natco Pharma
11.6.1 Natco Pharma Company Detail
11.6.2 Natco Pharma Business Overview
11.6.3 Natco Pharma Armodafinil Introduction
11.6.4 Natco Pharma Revenue in Armodafinil Business (2019-2024)
11.6.5 Natco Pharma Recent Development
11.7 Aurobindo
11.7.1 Aurobindo Company Detail
11.7.2 Aurobindo Business Overview
11.7.3 Aurobindo Armodafinil Introduction
11.7.4 Aurobindo Revenue in Armodafinil Business (2019-2024)
11.7.5 Aurobindo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Armodafinil Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 50 mg Tablets
Table 3. Key Players of 150 mg Tablets
Table 4. Key Players of 200 mg Tablets
Table 5. Key Players of 250 mg Tablets
Table 6. Global Armodafinil Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Armodafinil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Armodafinil Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Armodafinil Market Share by Region (2019-2024)
Table 10. Global Armodafinil Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Armodafinil Market Share by Region (2025-2030)
Table 12. Armodafinil Market Trends
Table 13. Armodafinil Market Drivers
Table 14. Armodafinil Market Challenges
Table 15. Armodafinil Market Restraints
Table 16. Global Armodafinil Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Armodafinil Market Share by Players (2019-2024)
Table 18. Global Top Armodafinil Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil as of 2023)
Table 19. Ranking of Global Top Armodafinil Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Armodafinil Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Armodafinil Product Solution and Service
Table 23. Date of Enter into Armodafinil Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Armodafinil Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Armodafinil Revenue Market Share by Type (2019-2024)
Table 27. Global Armodafinil Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Armodafinil Revenue Market Share by Type (2025-2030)
Table 29. Global Armodafinil Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Armodafinil Revenue Market Share by Application (2019-2024)
Table 31. Global Armodafinil Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Armodafinil Revenue Market Share by Application (2025-2030)
Table 33. North America Armodafinil Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Armodafinil Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Armodafinil Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Armodafinil Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Armodafinil Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Armodafinil Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Armodafinil Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Armodafinil Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Armodafinil Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Armodafinil Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Armodafinil Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Armodafinil Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Armodafinil Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Armodafinil Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Armodafinil Market Size by Country (2025-2030) & (US$ Million)
Table 48. Teva Company Detail
Table 49. Teva Business Overview
Table 50. Teva Armodafinil Product
Table 51. Teva Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 52. Teva Recent Development
Table 53. Mylan Company Detail
Table 54. Mylan Business Overview
Table 55. Mylan Armodafinil Product
Table 56. Mylan Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 57. Mylan Recent Development
Table 58. Apotex Company Detail
Table 59. Apotex Business Overview
Table 60. Apotex Armodafinil Product
Table 61. Apotex Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 62. Apotex Recent Development
Table 63. Lupin Company Detail
Table 64. Lupin Business Overview
Table 65. Lupin Armodafinil Product
Table 66. Lupin Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 67. Lupin Recent Development
Table 68. Sandoz Company Detail
Table 69. Sandoz Business Overview
Table 70. Sandoz Armodafinil Product
Table 71. Sandoz Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 72. Sandoz Recent Development
Table 73. Natco Pharma Company Detail
Table 74. Natco Pharma Business Overview
Table 75. Natco Pharma Armodafinil Product
Table 76. Natco Pharma Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 77. Natco Pharma Recent Development
Table 78. Aurobindo Company Detail
Table 79. Aurobindo Business Overview
Table 80. Aurobindo Armodafinil Product
Table 81. Aurobindo Revenue in Armodafinil Business (2019-2024) & (US$ Million)
Table 82. Aurobindo Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Armodafinil Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Armodafinil Market Share by Type: 2023 VS 2030
Figure 3. 50 mg Tablets Features
Figure 4. 150 mg Tablets Features
Figure 5. 200 mg Tablets Features
Figure 6. 250 mg Tablets Features
Figure 7. Global Armodafinil Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Armodafinil Market Share by Application: 2023 VS 2030
Figure 9. Obstructive Sleep Apnea (OSA) and Narcolepsy Case Studies
Figure 10. Shift Work Disorder (SWD) Case Studies
Figure 11. Patients with Severe Hepatic Impairment Case Studies
Figure 12. Geriatric Patients Case Studies
Figure 13. Armodafinil Report Years Considered
Figure 14. Global Armodafinil Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Armodafinil Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Armodafinil Market Share by Region: 2023 VS 2030
Figure 17. Global Armodafinil Market Share by Players in 2023
Figure 18. Global Top Armodafinil Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Armodafinil Revenue in 2023
Figure 20. North America Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Armodafinil Market Share by Country (2019-2030)
Figure 22. United States Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Armodafinil Market Share by Country (2019-2030)
Figure 26. Germany Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Armodafinil Market Share by Region (2019-2030)
Figure 34. China Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Armodafinil Market Share by Country (2019-2030)
Figure 42. Mexico Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Armodafinil Market Share by Country (2019-2030)
Figure 46. Turkey Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Teva Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 49. Mylan Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 50. Apotex Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 51. Lupin Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 52. Sandoz Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 53. Natco Pharma Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 54. Aurobindo Revenue Growth Rate in Armodafinil Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
